BRUKINSA: payments to doctors
Payments that named BRUKINSA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $12.1M
- Providers
- 10,520
- Transactions
- 45,292
- Average per transaction
- $266
The per-transaction average — $266 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,520 providers the average total is $1,147, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Beigene USA, Inc. | $9,295,279 | 77.1% |
| Beone Medicines USA, Inc. | $2,095,472 | 17.4% |
| Beigene, Ltd. | $345,278 | 2.9% |
| Beigene (suzhou) Co., Ltd. | $210,618 | 1.7% |
| Beigene Switzerland GmbH | $112,550 | 0.9% |
| Beone Medicines AUS Pty Ltd | $3,750 | 0.0% |